Rationale and design of the multicenter randomized trial investigating the effects of levosimendan pretreatment in patients with low ejection fraction (≤40 %) undergoing CABG with cardiopulmonary bypass (LICORN study)

被引：0

作者：

Thibaut Caruba

Delphine Hourton

Brigitte Sabatier

Dominique Rousseau

Annick Tibi

Cécile Hoffart-Jourdain

Akim Souag

Nelly Freitas

Mounia Yjjou

Carla Almeida

Nathalie Gomes

Pascaline Aucouturier

Juliette Djadi-Prat

Philippe Menasché

Gilles Chatellier

Bernard Cholley

机构：

[1] Hôpital Européen Georges Pompidou,Department of Pharmacy

[2] AP-HP,Clinical Trial Unit and INSERM CIC

[3] Hôpital Européen Georges Pompidou,141

[4] AP-HP,Department of Anaesthesiology and Intensive Care

[5] Agence Générale des Equipements et des Produits de Santé (AGEPS),Department of Cardiovascular Surgery

[6] AP-HP,Département de la Recherche Clinique et du Développement (DRCD)

[7] Hôpital Européen Georges Pompidou,undefined

[8] AP-HP,undefined

[9] Hôpital Européen Georges Pompidou,undefined

[10] AP-HP,undefined

[11] Université Paris Descartes,undefined

[12] Sorbonne Paris Cité,undefined

[13] INSERM Centre de Recherche des Cordeliers UMR S 872 eq 22 Université Paris Descartes,undefined

[14] Hôpital Saint-Louis,undefined

[15] (AP-HP),undefined

来源：

Journal of Cardiothoracic Surgery | / 11卷

关键词：

Coronary artery bypass graft; Low cardiac output syndrome; High risk surgical patient; Levosimendan; Cardiac surgery; Perioperative management;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 38 条

[1] Rationale and design of the multicenter randomized trial investigating the effects of levosimendan pretreatment in patients with low ejection fraction (≤40 %) undergoing CABG with cardiopulmonary bypass (LICORN study)
Caruba, Thibaut
Hourton, Delphine
Sabatier, Brigitte
Rousseau, Dominique
Tibi, Annick
Hoffart-Jourdain, Cecile
Souag, Akim
Freitas, Nelly
Yjjou, Mounia
Almeida, Carla
Gomes, Nathalie
Aucouturier, Pascaline
Djadi-Prat, Juliette
Menasche, Philippe
Chatellier, Gilles
Cholley, Bernard
JOURNAL OF CARDIOTHORACIC SURGERY, 2016, 11
[2] Effect of Levosimendan on Low Cardiac Output Syndrome in Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass The LICORN Randomized Clinical Trial
Cholley, Bernard
Caruba, Thibaut
Grosjean, Sandrine
Amour, Julien
Ouattara, Alexandre
Villacorta, Judith
Miguet, Bertrand
Guinet, Patrick
Levy, FranOois
Squara, Pierre
Hamou, Nora Ait
Carillon, Aude
Boyer, Julie
Boughenou, Marie-Fazia
Rosier, Sebastien
Robin, Emmanuel
Radutoiu, Mihail
Durand, Michel
Guidon, Catherine
Desebbe, Olivier
Charles-Nelson, Anais
Menasche, Philippe
Rozec, Bertrand
Girard, Claude
Fellahi, Jean-Luc
Pirracchio, Romain
Chatellier, Gilles
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (06): : 548 - 556
[3] Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS) trial
Mehta, Rajendra H.
Van Diepen, Sean
Meza, James
Bokesch, Paula
Leimberger, Jeffrey D.
Tourt-Uhlig, Sandra
Swartz, Merri
Parrotta, Jodi
Jankowich, Rachael
Hay, Douglas
Harrison, Robert W.
Fremes, Stephen
Goodman, Shaun G.
Luber, John
Toller, Wolfgang
Heringlake, Matthias
Anstrom, Kevin J.
Levy, Jerrold H.
Harrington, Robert A.
Alexander, John H.
AMERICAN HEART JOURNAL, 2016, 182 : 62 - 71
[4] Calcium administration In patients undergoing CardiAc suRgery under cardiopulmonary bypasS (ICARUS trial): Rationale and design of a randomized controlled trial
Lomivorotov, Vladimir
Ponomarev, Dmitry
Boboshko, Vladimir
Shmyrev, Vladimir
Ismoilov, Samandar
Efremov, Sergey
Kamenshchikov, Nikolay
Akselrod, Boris
Pasyuga, Vadim
Urusov, Dmitry
Ovezov, Alexey
Evdokimov, Mikhail
Turchaninov, Alexander
Bogachev-Prokofiev, Alexander
Bukamal, Nazar
Afifi, Sarah
Belletti, Alessandro
Bellomo, Rinaldo
Landoni, Giovanni
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2021, 23
[5] Outcome impact of different tranexamic acid regimens in cardiac surgery with cardiopulmonary bypass (OPTIMAL): Rationale, design, and study protocol of a multicenter randomized controlled trial
Shi, Jia
Zhou, Chenghui
Liu, Sheng
Sun, Hansong
Wang, Yang
Yan, Fuxia
Pan, Wei
Zheng, Zhe
AMERICAN HEART JOURNAL, 2020, 222 : 147 - 156
[6] A randomized, double-blind, placebo-controlled trial investigating the effect of ticagrelor on saphenous vein graft patency in patients undergoing coronary artery bypass grafting surgery-Rationale and design of the POPular CABG trial
Willemsen, Laura M.
Janssen, Paul W. A.
Hackeng, Chris M.
Kelder, Johannes C.
Tijssen, Jan G. P.
van Straten, Albert H. M.
Soliman-Hamad, Mohammed A.
Deneer, Vera H. M.
Daeter, Edgar J.
Sonker, Uday
Klein, Patrick
ten Berg, Jurrien M.
AMERICAN HEART JOURNAL, 2020, 220 : 237 - 245
[7] The HF-POL study - the first real-life multicenter study of Polish patients with heart failure and left ventricular ejection fraction >40%: Study rationale and design
Lelonek, Malgorzata
Gasior, Mariusz
Grabowski, Marcin
KARDIOLOGIA POLSKA, 2022, 80 (11) : 1145 - 1147
[8] Rationale and Design of a Randomized, Double-Blind, Placebo Controlled Multicenter Trial to Study Efficacy, Security, and Long Term Effects of Intermittent Repeated Levosimendan Administration in Patients with Advanced Heart Failure: LAICA study
Garcia-Gonzalez, Martin J.
de Mora-Martin, Manuel
Lopez-Fernandez, Silvia
Lopez-Diaz, Javier
Martinez-Selles, Manuel
Romero-Garcia, Jose
Cordero, Marco
Lara-Padron, Antonio
Marrero-Rodriguez, Francisco
del Mar Garcia-Saiz, M.
Aldea-Perona, Ana
CARDIOVASCULAR DRUGS AND THERAPY, 2013, 27 (06) : 573 - 579
[9] Rationale and Design of a Randomized, Double-Blind, Placebo Controlled Multicenter Trial to Study Efficacy, Security, and Long Term Effects of Intermittent Repeated Levosimendan Administration in Patients with Advanced Heart Failure: LAICA study
Martín J. García-González
Manuel de Mora-Martín
Silvia López-Fernández
Javier López-Díaz
Manuel Martínez-Sellés
José Romero-García
Marco Cordero
Antonio Lara-Padrón
Francisco Marrero-Rodríguez
M. del Mar García-Saiz
Ana Aldea-Perona
Cardiovascular Drugs and Therapy, 2013, 27 : 573 - 579
[10] A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trial
de Waha, Antoinette
Sandner, Sigrid
von Scheidt, Moritz
Boening, Andreas
Koch-Buettner, Katharina
Hammel, Dieter
Hambrecht, Rainer
Danner, Bernhard C.
Schoendube, Friedrich A.
Goerlach, Gerold
Fischlein, Theodor
Schmoeckel, Michael
Oberhoffer, Martin
Schulz, Rainer
Walther, Thomas
Ziegelhoeffer, Tibor
Knosalla, Christoph
Schoenrath, Felix
Beyersdorf, Friedheim
Siepe, Matthias
Attmann, Tim
Misfeld, Martin
Mohr, Friedrich-Wilhelm
Sievers, Hans-Hinrich
Joost, Alexander
Putman, Leon M.
Laufer, Guenther
Hamm, Christian
Zeymer, Uwe
Kastrati, Adnan
Radke, Peter W.
Lange, Ruediger
Cremer, Jochen
Schunkert, Heribert
AMERICAN HEART JOURNAL, 2016, 179 : 69 - 76

← 1 2 3 4 →